These compounds were tested in MDR cervical adenocarcinoma P-gp overexpressing cells, together with vincristine and paclitaxel (in comparison with verapamil as a positive control), in order to access their MDR modulatory capacity. This evidence concerns the gene PGP and cervical adenocarcinoma.